Table II.
Survival and Mortality Patients of Papillary Thyroid Carcinoma With Lymph Node Metastases at Diagnosis
| Mortality | Survival | P‐value | |
|---|---|---|---|
| Number | 14 | 97 | |
| Age (year) | 63.3 ± 14.0 | 34.1 ± 11.8 | 0.0001 |
| Age (≥45, %) | 12 (85.7%) | 14 (14.4%) | 0.0001 |
| Gender (F, %) | 5 (35.7%) | 81 (85.5%) | 0.0001 |
| Tumor size | 4.6 ± 0.8 | 2.6 ± 0.1 | 0.0001 |
| Postoperative 1 month thyroglobulin (ng/ml) | 113 ± 59.0 | 62.5 ± 19.5 | 0.3636 |
| TNM stage (Stage I/II/III/IVA) a | 2/0/8/2 | 84/0/8/4 | – |
| Postoperative 131I accumulative dose (mCi) | 555 ± 141 | 183 ± 20 | 0.0001 |
| Disease‐free (%) | 0 | 44 (45.4%) | 0.0007 |
| Follow‐up period (year) | 9.4 ± 1.6 | 18.0 ± 0.5 | 0.0001 |
a
Three cases age over 45‐year‐old uncertained central or lateral dissection.